Category Archives: Spinal Cord Injury Treatment

A comprehensive plan for insurance coverage of rehabilitation services has been prepared by the Health Ministry and sent to the High Council for Insurance for approval. The plan includes a variety of services including speech therapy, occupational therapy, physiotherapy, psychological consultancy, orthosis and prosthesis application and rehabilitation for patients with cervical disorders. Patients with history of stroke and spinal cord injury as well as those suffering MS, Parkinsons disease and developmental disorders will benefit from the scheme once approved. Insurance will pay only for services at comprehensive rehabilitation centers abiding by Labor Ministry regulations, and hospitals with inpatient facilities for a group of conditions including stroke, spinal cord injury, Parkinson, MS and developmental disorders, said Mohammad Taqi Joghataei, advisor to the health minister, IRNA reported. Rehabilitation of sensory and cognitive function typically involves methods for retraining neural pathways or training new neural pathways to regain or improve neurocognitive functioning that has been diminished by disease or trauma. It is the third phase of healthcare services after treatment and recovery, and without rehabilitation it can lead to the failure of the treatment procedures. This branch of medicine has been ignored for years. For many of the rehab services tariffs have not … Continue reading →

InVivo Therapeutics (NASDAQ:NVIV) perks up13%premarket on modest volume in response to its announcement that two spinal cord injury patients in the INSPIRE study who received its Neuro-Spinal Scaffold have improved from sensory incomplete AIS B status to motor incomplete AIS C, the second and third patients to reach this level. CEO and ChairmanMark Perrin says, We are excited that these two patients have continued to progress beyond the period of early improvement. Three of the five patients with an AIS conversion in INSPIRE have demonstrated motor recovery and are now classified as AIS C conversions. Having assessments of motor improvements occurring one or two years post-implantation is uncommon and may be indicative of prolonged neural repair. TheNeuro-Spinal Scaffoldis a bioresorbable polymer scaffold that is designed to treat acute spinal cord injury. It is implanted at the injury site within a spinal cord contusion where it provides structural support to spinal tissue and a supportive matrix that facilitates endogenous tissue repair. It degrades over a period of several weeks. Previously: InVivo to amend INSPIRE protocol, up to 40 new patients to participate; shares slump 6% on efficacy implications (April 13) Read the rest here: Two spinal cord injury patients show improvement … Continue reading →

This form of alternative care typically treats mechanical disorders of the musculoskeletal system with an emphasis on the spine, although I have had chiropractors adjust my hips, feet and shoulders. Chiropractic care is somewhat controversial with mainstream practitioners, including some who believe it is sustained by pseudo-scientific ideas such as subluxation and "innate intelligence" that are not based on sound research. In my own reviews of studies on chiropractic manipulation, I have not found evidence that it is effective long term for chronic pain, except for treatment of back pain. However, chiropractic care is well established in the U.S. and Canada as a form of alternative treatment. It is often combined with other manual-therapy professions, including massage therapy, osteopathy and physical therapy. Craniosacral Therapy Craniosacral therapy (CST) takes a whole-person approach to healing, and the inter-connections of the mind, body and spirit. Practitioners say it is an effective form of treatment for a wide range of illnesses, and encourages vitality and a sense of well-being. Because it is non-invasive, it is suitable for people of all ages, including babies, children and the elderly. The intent of CST treatment is to enhance the body's own self-healing and self-regulating capabilities. This is … Continue reading →

By Jesse Pound, Staff Writer Photo: Photos By John Davenport /San Antonio Express-News Manuel A. Riquelme works in a lab Friday at UT Health San Antonio. UT Healths licensing deal with gAlaMab Therapeutics is based on the work of researcher Jean Jiang. Manuel A. Riquelme works in a lab Friday at UT Health San Antonio. UT Healths licensing deal with gAlaMab Therapeutics is based on the work of researcher Jean Jiang. UT Health San Antonio signs potential $114M deal with Chinese pharma firm UT Health San Antonio announced Friday a landmark licensing deal worth up to $114 million with a Chinese pharmaceutical company to develop new treatments for spinal cord injuries and breast cancer. AlaMab Therapeutics, a subsidiary of CSPC Pharmaceutical Group in China, will make an upfront payment of $4.5 million to UT Health San Antonio and UTHealth in Houston to license two antibodies found by local researcher Jean Jiang. The first antibody inhibits neural inflammatory reactions after spinal cord injury, while the other helps treat breast cancer after it invades the bone. Jiang has partnered with Zhiqiang An of UTHealth in Houston to humanize the antibodies for more trials. Dr. William Henrich, president of UT Health San Antonio, … Continue reading →

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV)today announced that the UCHealth Memorial Hospital in Colorado Springs, CO has been added as a clinical site for The INSPIRE Study: InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord Injury. Thomas Schroeppel, M.D., has been named Principal Investigator at the site. I am thrilled to bring The INSPIRE Study and this innovative technology to the UCHealth Memorial Hospital, especially to help those who suffer from the devastating condition of spinal cord injury, Dr. Schroeppel said. Mark Perrin, InVivos CEO and Chairman, said, We are pleased to have Dr. Schroeppel and his team as part of the INSPIRE study. The UCHealth Memorial Hospitals experience with spinal cord injury will be a valuable asset to the INSPIRE study as we look to completing enrollment. There are now 32 clinical sites participating in the clinical study: For more information, please visit the companys ClinicalTrials.gov registration site: http://clinicaltrials.gov/ct2/show/study/NCT02138110 About the Neuro-Spinal Scaffold Implant Following acute spinal cord injury, surgical implantation of the biodegradable Neuro-Spinal Scaffold within the decompressed and debrided injury epicenter is intended to support appositional healing, thereby reducing post-traumatic cavity … Continue reading →

In Brief A new study has revealed the potential for cortical targets to improve motor function in those struggling with paralysis. Cortical targets are relatively unexplored territory for treatment, so building off this research could lead to even more exciting discoveries. A New Target Monica A. Perez, P.T., Ph. D. and her colleagues at the University of Miami have produced the first evidence that cortical targets could improve motor function in patients who are paralyzed, specifically by spinal cord injury (SCI). The results of their studyhave been published in Brain. In previous treatments and studies, sites within the central nervous system have been targeted to try to improve motor function. However, whether or not cortical targets areas on the outer layer of the brains cerebrum could improve motor function in patients was unknown. To explore this potential relationship, the research group noninvasively stimulated the area using magnets. They found that, after this stimulation, the finger muscles of thosewith SCI exerted more force and produced more electromyographic activity, and the patients ability to grasp objects with their hands wassignificantly improved. Dr. Jonathan R. Wolpaw, M.D. Director of the National Center for Adaptive Neurotechnologies Albany, New York, sees great promise in Perezs … Continue reading →

WALLINGFORD >> Even in a hospital floor full of nurses, a mother of a teenager recovering from a spinal cord or brain injury never wants to be far away. I can hear mom in my sleep, said Shirleyann Pompea, whose daughter fractured her neck and injured her spinal cord in April. I can get there before the call bell. Pompeas daughter, Janelle, lived at Gaylord Specialty Healthcare for close to two months while she recovered from the injuries she suffered in a car accident in Redding. And every night of her stay in Wallingford, Pompea or her husband, have been right next door. For the 49 days shes been here, weve been here, Pompea said on a recent day her daughter was set to finally go home. Advertisement The Adolescent Spinal Cord Injury Unit at the Gaylord Hospital was recently recognized by the Greater New Haven Chamber of Commerces Health Care Council for its innovative approach to caring for teenagers and their families. Gaylord Specialty Healthcare/Gaylord Hospital serves approximately 1,400 inpatients and 6,000 outpatients every year. The hospital specializes in care for complex injuries where patients require intensive rehabilitation. The Adolescent Spinal Cord Injury Unit opened last spring and is … Continue reading →

Spine Biologics Market Zion Market Research, the market research group announced the analysis report titled Spine Biologics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 20162024 Global Spine Biologics Market: Overview Spine biologics is a treatment that is used during the spine fusion surgery for the treatment of spinal deformities that include spinal cord injuries, trauma, degenerative disc disease, and tumors. It stimulates the growth of the bone formation through different stages which include inflammatory, repair, and remodeling. Spine biologics are used in the treatment of symptomatic deformity to achieve successful arthrodesis. Spine biologics is a minimally invasive method and it requires less time as compared to that of open surgical procedures. Request Free Sample Report @https://www.zionmarketresearch.com/sample/spine-biologics-market Global Spine Biologics Market: Growth Factors Major factors that are driving the spine biologics market growth include a rise in the number of geriatric population, benefits provided by spine biologics is faster recovery, minimal postoperative time, and ability to activate cellular growth. Spinal disorders are most common in men and women over 50 years. Spinal injuries can be due to the enlargement of bones & joints, thickening of the band of the tissue, which supports the spine. This is the key … Continue reading →

The use of long-term catheterisation to manage insensate bladders, often associated with spinal cord injury (SCI), increases the risk of microbial colonisation and infection of the urinary tract. Urinary tract infection (UTI) is typically diagnosed and treated based on the culturing of organisms from the urine, although this approach overlooks low titer, slow growing and non-traditional pathogens. Here, we present an investigation of the urinary tract microbiome in catheterised SCI individuals, using T-RFLP and metagenomic sequencing of the microbial community. We monitored three neurogenic patients over a period of 12 months, who were part of a larger study investigating the efficacy of probiotics in controlling UTIs, to determine how their urinary tract microbial community composition changed over time and in relation to probiotic treatment regimens. Bacterial biofilms adherent to urinary catheters were examined as a proxy for bladder microbes. The microbial community composition of the urinary tract differed significantly between individuals. Probiotic therapy resulted in a significant change in the microbial community associated with the catheters. The community also changed as a consequence of UTI and this shift in community composition preceded the clinical diagnosis of infection. Changes in the microbiota due to probiotic treatment or infection were transient, resolving … Continue reading →

RESEARCHERS in Scotland are leading the drive to develop a new generation of multiple sclerosis drugs designed to reverse symptoms in patients with more advanced disability. The only MS drugs currently available treat the earlier, inflammatory stages of the disease and cannot repair the nerve damage which causes problems with speech and mobility. However, scientists in Edinburgh and Glasgow are now leading projects funded by MS Society Scotland which they hope will eventually produce treatments which can repair myelin - the protective sheath around nerve cells which is destroyed in MS. Dr Anna Williams, a neurologist at Edinburgh University's Centre for Regenerative Medicine, said: "Myelin is like the insulation on wires - it's there to make your nerves conduct electricity better. If it comes off, your nerves don't conduct electricity well so you might want to move your leg but find it more difficult to do so because the electrical impulse isn't being transmitted properly from the brain to the muscle. In the longer term if the myelin isn't there then the nerve itself dies and people get stuck with disability. "What we want to do is persuade the brain to put the myelin back on these nerves and stop … Continue reading →